Shenzhen, China-based BGI-Shenzhen has completed a $117.6 million deal to buy Complete Genomics. 

The deal was originally announced in September, but the companies had to receive antitrust and CFIUS clearance in the U.S. The deal also had to recieve regulatory approval in China.

Subscribe Now

Complete access to real-time information and analysis of news and trends in the industry.

14-Day Free Trial

No credit card required. Complete access to articles, breaking news and industry data.